Early Kidney Disease Detection
The proteomic signature detects kidney disease risk before significant damage becomes clinically apparent. Improved early prediction creates eligibility for therapeutic strategies before substantial kidney function is lost. The signature e…
1 sources - 3 claims
The proteomic signature detects kidney disease risk before significant damage becomes clinically apparent. Improved early prediction creates eligibility for therapeutic strategies before substantial kidney function is lost. The signature enables more efficient identification and recruitment of high-risk individuals into clinical research studies.